Microvessel density in prostate cancer: Lack of correlation with tumor grade, pathologic stage, and clinical outcome

Urology

Volumn 53, Issue 3, 1999, Pages 542-547

  Rubin, M A ^a   Buyyounouski, M ^a   Bagiella, E ^a   Sharir, S ^a   Neugut, A ^a   Benson, M ^a   De la Taille, A ^a   Katz, A E ^a   Olsson, C A ^a   Ennis, R D ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER STAGING; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MICROVASCULARIZATION; OBSERVER VARIATION; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROSTATECTOMY; REPRODUCIBILITY;

AGED; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 0033106005     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(98)00561-5     Document Type: Article

References (26)

1. Ogawa Y., Chung Y.S., Nakata B., et al. Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen. Br J Cancer. 71:1995;1297-1301.
2. Weidner N. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat. 36:1995;169-180.
3. Delahunt B., Bethwaite P.B., Thornton A. Prognostic significance of microscopic vascularity for clear cell renal cell carcinoma. Br J Urol. 80:1997;401-404.
4. Kirschner C.V., Alanis-Amezcua J.M., Martin V.G., et al. Angiogenesis factor in endometrial carcinoma a new prognostic indicator? Am J Obstet Gynecol. 174:1996;1879-1884.
5. Engel C.J., Bennett S.T., Chambers A.F., et al. Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging. Am J Surg Pathol. 20:1996;1260-1265.
6. Tomisaki S., Ohno S., Ichiyoshi Y., et al. Microvessel quantification and its possible relation with liver metastasis in colorectal cancer. Cancer. 77:1996;1722-1728.
7. Weidner N., Carroll P.R., Flax J., et al. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol. 143:1993;401-409.
8. Silberman M.A., Partin A.W., Veltri R.W., et al. Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate. Cancer. 79:1997;772-779.
9. Lissbrant I.F., Stattin P., Damber J.E., et al. Vascular density is a predictor of cancer-specific survival in prostatic carcinoma. Prostate. 33:1997;38-45.
10. Foss A.J., Alexander R.A., Jefferies L.W., et al. Microvessel count predicts survival in uveal melanoma. Cancer Res. 56:1996;2900-2903.
11. Partin A.W., Kattan M.W., Subong E.N., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA. 277:1997;1445-1451.
12. de Jong J.S., van Diest P.J., Baak J.P. Heterogeneity and reproducibility of microvessel counts in breast cancer. Lab Invest. 73:1995;922-926.
13. Gasparini G., Bonoldi E., Viale G., et al. Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas. Int J Cancer. 69:1996;205-211.
14. Bancher-Todesca D., Obermair A., Bilgi S., et al. Angiogenesis in vulvar intraepithelial neoplasia. Gynecol Oncol. 64:1997;496-500.
15. Leon S.P., Folkerth R.D., Black P.M. Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer. 77:1996;362-372.
16. Jaeger T.M., Weidner N., Chew K., et al. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J Urol. 154:1995;69-71.
17. Hall M.C., Troncoso P., Pollack A., et al. Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy. Urology. 44:1994;869-875.
18. Maeda K., Chung Y.S., Takatsuka S., et al. Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma. Br J Cancer. 72:1995;319-323.
19. Kohlberger P.D., Obermair A., Sliutz G., et al. Quantitative immunohistochemistry of factor VIII-related antigen in breast carcinoma a comparison of computer-assisted image analysis with established counting methods . Am J Clin Pathol. 105:1996;705-710.
20. MacLennan G.T., Bostwick D.G. Microvessel density in renal cell carcinoma lack of prognostic significance . Urology. 46:1995;27-30.
21. Gettman M., Bergstralh E., Blute M., et al. Prediction of patient outcome in pathologic stage T2 adenocarcinoma of the prostate lack of significance for microvessel density analysis . Urology. 51:1998;79-85.
22. Hegde P.U., Brenski A.C., Caldarelli D.D., et al. Tumor angiogenesis and p53 mutations prognosis in head and neck cancer . Arch Otolaryngol Head Neck Surg. 124:1998;80-85.
23. Bettencourt M.-C., Bauer J.J., Sesterhenn I.A., et al. CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy. J Urol. 160:1998;459-465.
24. Bostwick D.G., Wheeler T.M., Blute M., et al. Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. Urology. 48:1996;47-57.
25. Brawer M.K., Deering R.E., Brown M., et al. Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity. Cancer. 73:1994;678-687.
26. Schoell W.M., Pieber D., Reich O., et al. Tumor angiogenesis as a prognostic factor in ovarian carcinoma quantification of endothelial immunoreactivity by image analysis . Cancer. 80:1997;2257-2262.